Exploring the implications of FDA’s renewed focus and commitment to expand the use of accelerated approval for gene therapy products.
Emily Marden, JD
Advertisement
Senior Counsel, Sidley Austin LLP
Articles by Emily Marden, JD
Advertisement
Latest Updated Articles
Accelerated Approval and the Promise of Gene TherapyPublished: September 27th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
Assay Reproducibility in Hemostasis Diagnostics: Practical Methods to Reduce Variability and Strengthen Trial Outcomes
3
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
